Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Opko Health Inc
Nieuws
Opko Health Inc
OPK
NAS
: OPK
| ISIN: US68375N1037
14/11/2024
1,620 USD
(+1,25%)
(+1,25%)
14/11/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
2 juli 2024 ·
NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner
· Persbericht
28 maart 2024 ·
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
· Persbericht
28 februari 2024 ·
NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st
· Persbericht
5 februari 2024 ·
NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China
· Persbericht
7 november 2023 ·
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
· Persbericht
29 september 2023 ·
Thinking about buying stock in Blue Apron Holdings, OceanPal, OPKO Health, Bionomics, or Aytu Biopharma?
· Persbericht
9 februari 2023 ·
BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings
· Persbericht
16 maart 2022 ·
GeneDx Announces Discovery of 200 New and Expanded Genetic Conditions
· Persbericht
1 maart 2022 ·
Saol Therapeutics and GeneDx, Inc. Collaborate to Detect Patients with Rare Mitochondrial Disease
· Persbericht
29 november 2021 ·
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
· Persbericht
21 september 2021 ·
GeneDx Announces the Sequencing of More Than 300,000 Clinical Patient Exomes
· Persbericht
16 augustus 2021 ·
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
· Persbericht
22 juni 2021 ·
BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry
· Persbericht
27 april 2021 ·
Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year
· Persbericht
1 april 2021 ·
BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball
· Persbericht
26 maart 2021 ·
BioReference Laboratories Expands COVID-19 School Testing Program
· Persbericht
3 februari 2021 ·
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021
· Persbericht
26 januari 2021 ·
OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia
· Persbericht
26 januari 2021 ·
OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing
· Persbericht
13 januari 2021 ·
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe